Scholars Central

Conference abstractPublished 2 Oct 2017

Synthesis and Structures of Pincer-Type Rhodium(III) complexes; Reactivity Toward Small Biomolecules, calf thymus DNA (CT-DNA) and bovine serum albumin (BSA)

Authors: Jovana V Bogojeski, Milan M Milutinoviandad, Olivera Klisuric, Sofi K C Elmroth, Andreas Scheurer, Zivadin D Bugarcic

University of Kragujevac, Serbia University of Novi Sad, Serbia UniversitÃ?¤t Erlangen-NÃ?¼rnberg, Germany Lund University, Sweden

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A few novel rhodium(III) complex [RhIII(X)Cl3] (X = pyridin-bis(pirazole) ligands) were synthesized containing a pincer type, tridentate nitrogenâÂ?Â?donor chelate system. All complexes were fully characterized, single crystal X-ray structure analysis has been done. The reactivity of the synthesized complex toward small biomolecules (L-methionine (L-Met), guanosine-5âÂ?Â?-monophosphate (5âÂ?Â?-GMP), L-histidine (L-His) and glutathione (GSH) and to a series of duplex DNAs and RNA was investigated. These measurements showed that the synthesized complex has a good affinity toward studied ligands and the obtained order of reactivity is: 5'-GMP > GSH >L-Met > L-His. Duplex RNA reacts faster than duplex DNA, while shorter duplex DNA (15mer GG) reacts faster compared with 22mer GG duplex DNA. In addition, a higher reactivity is achieved with a DNA duplex with centrally located GG-sequence than with 22GTG duplex, in which GG sequence is separated by a T base. Furthermore, the interaction of this metal complex to calf thymus DNA (CT-DNA) and bovine serum albumin (BSA) was further examined by absorption (UV-Vis) and emission spectral studies (EthBr displacement studies). Overall, the studied complex exhibited good DNA and BSA interaction ability. All obtained results in this study indicate that the introduction of pincer-type spectator ligand can be used to improve the reactivity of rhodium(III) complexes. Together, these observations show the reactivity characteristics needed for a potential anti-tumor agent, with the ability to target both DNA and proteins. Every new contribution in this field highly is warranted due to the current lack of clinically used metallo-based alternatives to cisplatin.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jovana V Bogojeski”
  • BylineArticles whose byline prints “Milan M Milutinoviandad”
  • BylineArticles whose byline prints “Olivera Klisuric”
  • BylineArticles whose byline prints “Sofi K C Elmroth”
  • BylineArticles whose byline prints “Andreas Scheurer”
  • BylineArticles whose byline prints “Zivadin D Bugarcic”